Vichy Laboratoires Embraces Longevity Science in Skin and Hair Care
PARIS – Vichy Laboratoires, a prominent name in dermocosmetics and a subsidiary of L’Oréal, is making significant strides in the field of longevity, focusing on an integrative approach to skin and hair health. This initiative comes as the brand prepares to present its latest innovations at the European Academy of Dermatology and Venereology (EADV) symposium, which runs from Wednesday to Saturday in Paris.
A New Era in Dermocosmetics
Vichy’s commitment to longevity is underscored by the launch of two groundbreaking products: the Vichy Neovadiol Longevity Cream and the Dercos Aminexil Clinical R.E.G.E.N. Booster. Vincent Chauvière, the global brand president of Vichy Laboratoires, emphasized that longevity is a core focus for the brand, which was founded on the principle that beauty is intrinsically linked to skin health.
“Longevity science allows us to delve deeper into the root causes of aging,” Chauvière stated. This approach enables the brand to target biological age rather than merely chronological age, offering a more nuanced understanding of skin and hair health.
Understanding Aging: The Science Behind Longevity
The concept of longevity science is not new; it has been a topic of interest for researchers and consumers alike. Historically, the beauty industry has often focused on superficial solutions to aging, but Vichy’s approach aims to address the underlying biological mechanisms. This shift is particularly relevant as the global population ages. By 2030, it is projected that 1.4 billion people will be over the age of 60, a demographic that is increasingly influential in the beauty market.
In January, Vichy introduced the Collagen Specialist 16 line, designed to enhance the skin’s ability to regenerate the 16 types of collagen essential for youthful appearance. This product line laid the groundwork for the new offerings, which are even more closely aligned with the principles of longevity.
Targeting the Baby Boomer Market
The Neovadiol Longevity Cream is specifically aimed at Baby Boomers, a demographic that represents a significant market opportunity for Vichy. According to Chauvière, this age group is the second most recommended by dermatologists and is known for its substantial spending on skincare-averaging around $400 annually in the U.S., nearly 2.5 times more than Gen Z consumers.
The new cream is touted as a breakthrough innovation, designed to enhance the skin’s ability to regenerate healthy tissue. Clinical studies suggest that it can increase youthful skin tissue by 31% and restore up to 42% of skin volume. Priced at approximately 80 euros for a 100-ml jar, it aims to provide a scientifically-backed solution for aging skin.
Innovations in Hair Care
Vichy is also venturing into the realm of hair care with the Dercos Aminexil Clinical R.E.G.E.N. Booster. This product is based on the premise that the scalp is an extension of the skin, and thus, hair health is intrinsically linked to scalp health. The serum works at the hair bulb level, claiming not only to slow hair loss but also to stimulate new growth.
Chauvière described this product as a significant advancement in hair-loss treatments, marking a new era in the science of hair longevity. The R.E.G.E.N. Booster has already shown promising results, with clinical trials indicating an increase of over 14,000 hairs within 12 weeks of use.
The Science Behind the R.E.G.E.N. Booster
Paulina Andrycz, global medical communications director at L’Oréal Dermatological Beauty, explained that the R.E.G.E.N. Booster was developed using a “longevity wheel,” a tool created by the company’s research and innovation department. This wheel categorizes the various hallmarks influencing longevity and identifies three key areas to address: structural, metabolic, and signaling.
The formula for the R.E.G.E.N. Booster includes the Aminexil Longevity Complex, which consists of 1% Aminexil, 3% gingerol, and a NAD+ Booster made from niacinamide. Backed by over 20 clinical studies, this product aims to redefine hair health standards.
Market Performance and Future Prospects
Vichy has experienced robust growth, ending the previous year with a 10% increase in sales, one of the best performances in the last two decades. The Dercos line has been a significant contributor to this success, with sales soaring nearly 40% globally. Chauvière noted that the R.E.G.E.N. Booster is expected to further drive growth for the Dercos brand, which has a wide geographic reach, including Europe, Latin America, and China.
Dercos has recently emerged as the most recommended brand among dermatologists, with over 90,000 professionals endorsing its efficacy. Chauvière believes that hair care will play a pivotal role in the future of dermocosmetics, particularly as consumers increasingly seek scientifically validated solutions for their beauty needs.
Conclusion
Vichy Laboratoires is at the forefront of a transformative movement in the beauty industry, where longevity science is becoming a cornerstone of product development. By focusing on the biological aspects of aging, the brand is not only addressing the needs of an aging population but also setting new standards in skin and hair care. As the market continues to evolve, Vichy’s integrative approach may well define the future of dermocosmetics, offering consumers innovative solutions that prioritize health alongside beauty.
